title: Therapy-related myeloid neoplasm in methotrexate-associated lymphoproliferative disease in a rheumatoid arthritis patient.
authors.affiliation: Departments of Hematology, Saitama Medical Center, Saitama Medical University.
authors.forename: Michihide
authors.initials: M
authors.lastname: Tokuhira
authors.forename: Yuta
authors.initials: Y
authors.lastname: Kimura
authors.forename: Tomoe
authors.initials: T
authors.lastname: Nemoto
authors.forename: Morihiko
authors.initials: M
authors.lastname: Sagawa
authors.forename: Tatsuki
authors.initials: T
authors.lastname: Tomikawa
authors.forename: Ryota
authors.initials: R
authors.lastname: Sakai
authors.forename: Ayumi
authors.initials: A
authors.lastname: Okuyama
authors.forename: Koichi
authors.initials: K
authors.lastname: Amano
authors.forename: Morihiro
authors.initials: M
authors.lastname: Higashi
authors.forename: Jun-Ichi
authors.initials: J
authors.lastname: Tamaru
authors.forename: Shigehisa
authors.initials: S
authors.lastname: Mori
authors.forename: Takayuki
authors.initials: T
authors.lastname: Tabayashi
authors.forename: Reiko
authors.initials: R
authors.lastname: Watanabe
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kizaki
mesh_terms: D001172:Arthritis, Rheumatoid / Q000150:complications*; D001853:Bone Marrow / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017404:In Situ Hybridization, Fluorescence; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000209:etiology*; D008232:Lymphoproliferative Disorders / Q000139:chemically induced* / Q000175:diagnosis; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000209:etiology*
chemical_list: D007166:Immunosuppressive Agents; D008727:Methotrexate